{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:01:00Z","timestamp":1793026860955,"version":"4.5.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007202","name":"Gouvernement du Canada | Instituts de Recherche en Sant\u00e9 du Canada | CIHR Skin Research Training Centre","doi-asserted-by":"publisher","award":["153234, 158225, 168933, 191847"],"award-info":[{"award-number":["153234, 158225, 168933, 191847"]}],"id":[{"id":"10.13039\/501100007202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012118","name":"Ontario Institute for Cancer Research","doi-asserted-by":"publisher","award":["IA-031"],"award-info":[{"award-number":["IA-031"]}],"id":[{"id":"10.13039\/100012118","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CIHR = Canadian Institute of Health Research OICR = Ontario Institute for Cancer Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-67856-5","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T10:01:39Z","timestamp":1766484099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prostate cancer cells converge to an inflammatory-like state upon metastatic dissemination"],"prefix":"10.1038","volume":"16","author":[{"given":"Tina","family":"Keshavarzian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1724-7061","authenticated-orcid":false,"given":"Kira","family":"Furlano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Grillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisanne","family":"Mout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Arlidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizan","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7071-5114","authenticated-orcid":false,"given":"Ankita","family":"Nand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Migle","family":"Mikutenaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evdoxia","family":"Karadoulama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9830-3987","authenticated-orcid":false,"given":"Ashish","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth L.","family":"Pezzuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Heilmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Sykora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Minner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9557-4653","authenticated-orcid":false,"given":"Thorsten","family":"Schlomm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2898-3363","authenticated-orcid":false,"given":"Housheng Hansen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3917-5524","authenticated-orcid":false,"given":"Joachim","family":"Weischenfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2554-3952","authenticated-orcid":false,"given":"Christoph","family":"Plass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5792-3901","authenticated-orcid":false,"given":"Clarissa","family":"Gerh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0929-9478","authenticated-orcid":false,"given":"Mathieu","family":"Lupien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"67856_CR1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nrclinonc.2014.68","volume":"11","author":"AJ Chang","year":"2014","unstructured":"Chang, A. J., Autio, K. A., Roach, M. 3rd & Scher, H. I. High-risk prostate cancer-classification and therapy. Nat. Rev. Clin. Oncol. 11, 308\u2013323 (2014).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"67856_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","volume":"7","author":"RJ Rebello","year":"2021","unstructured":"Rebello, R. J. et al. Prostate cancer. Nat. Rev. Dis. Primers 7, 9 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"67856_CR3","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/ng.3315","volume":"47","author":"PC Boutros","year":"2015","unstructured":"Boutros, P. C. et al. Spatial genomic heterogeneity within localized, multifocal prostate cancer. Nat. Genet. 47, 736\u2013745 (2015).","journal-title":"Nat. Genet."},{"key":"67856_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s43018-023-00692-y","volume":"5","author":"EW Warner","year":"2024","unstructured":"Warner, E. W. et al. Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping. Nat. Cancer 5, 114\u2013130 (2024).","journal-title":"Nat. Cancer"},{"key":"67856_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47664-z","volume":"15","author":"N Zhang","year":"2024","unstructured":"Zhang, N. et al. High clonal diversity and spatial genetic admixture in early prostate cancer and surrounding normal tissue. Nat. Commun. 15, 3475 (2024).","journal-title":"Nat. Commun."},{"key":"67856_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48629-y","volume":"15","author":"U Singhal","year":"2024","unstructured":"Singhal, U. et al. Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis. Nat. Commun. 15, 4341 (2024).","journal-title":"Nat. Commun."},{"key":"67856_CR7","first-page":"27","volume":"1","author":"SMG Espiritu","year":"2018","unstructured":"Espiritu, S. M. G. et al. The evolutionary landscape of localized prostate cancers drives clinical aggression. Cell 1, 27 (2018).","journal-title":"Cell"},{"key":"67856_CR8","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1158\/1078-0432.CCR-20-0168","volume":"26","author":"KH Stopsack","year":"2020","unstructured":"Stopsack, K. H. et al. Oncogenic genomic alterations, clinical phenotypes, and outcomes in metastatic castration-sensitive prostate cancer. Clin. Cancer Res. 26, 3230\u20133238 (2020).","journal-title":"Clin. Cancer Res."},{"key":"67856_CR9","first-page":"1336","volume":"49","author":"KJ Kron","year":"2017","unstructured":"Kron, K. J. et al. TMPRSS2\u2013ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer. Nat. Publ. Group 49, 1336\u20131345 (2017).","journal-title":"Nat. Publ. Group"},{"key":"67856_CR10","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41586-020-03147-x","volume":"590","author":"D Alonso-Curbelo","year":"2021","unstructured":"Alonso-Curbelo, D. et al. A gene-environment-induced epigenetic program initiates tumorigenesis. Nature 590, 642\u2013648 (2021).","journal-title":"Nature"},{"key":"67856_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature13108","volume":"506","author":"SC Mack","year":"2014","unstructured":"Mack, S. C. et al. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature 506, 445\u2013450 (2014).","journal-title":"Nature"},{"key":"67856_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/ng.3753","volume":"49","author":"OG McDonald","year":"2017","unstructured":"McDonald, O. G. et al. Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis. Nat. Genet. 49, 367\u2013376 (2017).","journal-title":"Nat. Genet."},{"key":"67856_CR13","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41586-024-08150-0","volume":"637","author":"A Moorman","year":"2025","unstructured":"Moorman, A. et al. Progressive plasticity during colorectal cancer metastasis. Nature 637, 947\u2013954 (2025).","journal-title":"Nature"},{"key":"67856_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"67856_CR15","doi-asserted-by":"publisher","first-page":"E1490","DOI":"10.1073\/pnas.1219992110","volume":"110","author":"L Magnani","year":"2013","unstructured":"Magnani, L. et al. Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer. Proc. Natl. Acad. Sci. 110, E1490\u2013E1499 (2013).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"67856_CR16","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s41588-019-0424-9","volume":"51","author":"K Grosselin","year":"2019","unstructured":"Grosselin, K. et al. High-throughput single-cell ChIP-seq identifies heterogeneity of chromatin states in breast cancer. Nat. Genet. 51, 1060\u20131066 (2019).","journal-title":"Nat. Genet."},{"key":"67856_CR17","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1493","author":"G Deblois","year":"2020","unstructured":"Deblois, G. et al. Epigenetic switch-induced viral mimicry evasion in chemotherapy resistant breast cancer. Cancer Discov. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-1493 (2020).","journal-title":"Cancer Discov."},{"key":"67856_CR18","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41588-020-0664-8","volume":"52","author":"MM Pomerantz","year":"2020","unstructured":"Pomerantz, M. M. et al. Prostate cancer reactivates developmental epigenomic programs during metastatic progression. Nat. Genet. 52, 790\u2013799 (2020).","journal-title":"Nat. Genet."},{"key":"67856_CR19","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1158\/2159-8290.CD-23-0331","volume":"13","author":"G Grillo","year":"2023","unstructured":"Grillo, G. et al. Transposable elements are co-opted as oncogenic regulatory elements by lineage-specific transcription factors in prostate cancer. Cancer Discov. 13, 2470\u20132487 (2023).","journal-title":"Cancer Discov."},{"key":"67856_CR20","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ccell.2019.10.005","volume":"36","author":"P Mazrooei","year":"2019","unstructured":"Mazrooei, P. et al. Cistrome partitioning reveals convergence of somatic mutations and risk variants on master transcription regulators in primary prostate tumors. Cancer Cell 36, 674\u2013689.e6 (2019).","journal-title":"Cancer Cell"},{"key":"67856_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07270-2","volume":"9","author":"S Stelloo","year":"2018","unstructured":"Stelloo, S. et al. Integrative epigenetic taxonomy of primary prostate cancer. Nat. Commun. 9, 4900 (2018).","journal-title":"Nat. Commun."},{"key":"67856_CR22","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/ng.3419","volume":"47","author":"MM Pomerantz","year":"2015","unstructured":"Pomerantz, M. M. et al. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. Nat. Genet. 47, 1346\u20131351 (2015).","journal-title":"Nat. Genet."},{"key":"67856_CR23","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cell.2018.05.037","volume":"174","author":"DY Takeda","year":"2018","unstructured":"Takeda, D. Y. et al. A somatically acquired enhancer of the androgen receptor is a noncoding driver in advanced prostate cancer. Cell 174, 422\u2013432 (2018).","journal-title":"Cell"},{"key":"67856_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","volume":"23","author":"S Chen","year":"2021","unstructured":"Chen, S. et al. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat. Cell Biol. 23, 87\u201398 (2021).","journal-title":"Nat. Cell Biol."},{"key":"67856_CR25","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1172\/JCI128212","volume":"129","author":"MP Labrecque","year":"2019","unstructured":"Labrecque, M. P. et al. Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer. J. Clin. Investig. 129, 4492\u20134505 (2019).","journal-title":"J. Clin. Investig."},{"key":"67856_CR26","doi-asserted-by":"publisher","first-page":"eabe1505","DOI":"10.1126\/science.abe1505","volume":"376","author":"F Tang","year":"2022","unstructured":"Tang, F. et al. Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets. Science 376, eabe1505 (2022).","journal-title":"Science"},{"key":"67856_CR27","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ccell.2018.10.016","volume":"34","author":"C Gerhauser","year":"2018","unstructured":"Gerhauser, C. et al. Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories. Cancer Cell 34, 996\u20131011.e8 (2018).","journal-title":"Cancer Cell"},{"key":"67856_CR28","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e29 (2021).","journal-title":"Cell"},{"key":"67856_CR29","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nmeth.4401","volume":"14","author":"AN Schep","year":"2017","unstructured":"Schep, A. N., Wu, B., Buenrostro, J. D. & Greenleaf, W. J. chromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data. Nat. Methods 14, 975\u2013978 (2017).","journal-title":"Nat. Methods"},{"key":"67856_CR30","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1016\/j.cell.2024.06.038","volume":"187","author":"Y Yang","year":"2024","unstructured":"Yang, Y. et al. Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes. Cell 187, 4790\u20134811.e22 (2024).","journal-title":"Cell"},{"key":"67856_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41585-020-00400-w","volume":"18","author":"MC Haffner","year":"2021","unstructured":"Haffner, M. C. et al. Genomic and phenotypic heterogeneity in prostate cancer. Nat. Rev. Urol. 18, 79\u201392 (2021).","journal-title":"Nat. Rev. Urol."},{"key":"67856_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature11232","volume":"489","author":"RE Thurman","year":"2012","unstructured":"Thurman, R. E. et al. The accessible chromatin landscape of the human genome. Nature 489, 75\u201382 (2012).","journal-title":"Nature"},{"key":"67856_CR33","doi-asserted-by":"crossref","unstructured":"Lu, X. et al. NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodeling. Nat. Genet. 57, 1966\u20131980 (2025).","DOI":"10.1038\/s41588-025-02265-4"},{"key":"67856_CR34","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1158\/0008-5472.CAN-24-1388","volume":"84","author":"KE Rodarte","year":"2024","unstructured":"Rodarte, K. E. et al. Neuroendocrine differentiation in prostate cancer requires ASCL1. Cancer Res 84, 3522\u20133537 (2024).","journal-title":"Cancer Res"},{"key":"67856_CR35","doi-asserted-by":"publisher","first-page":"e0213488","DOI":"10.1371\/journal.pone.0213488","volume":"14","author":"GT Lee","year":"2019","unstructured":"Lee, G. T. et al. TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer. PLoS ONE 14, e0213488 (2019).","journal-title":"PLoS ONE"},{"key":"67856_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.stem.2010.04.017","volume":"7","author":"X Zhang","year":"2010","unstructured":"Zhang, X. et al. Pax6 is a human neuroectoderm cell fate determinant. Cell Stem Cell 7, 90\u2013100 (2010).","journal-title":"Cell Stem Cell"},{"key":"67856_CR37","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/s41592-023-01938-4","volume":"20","author":"C Bravo Gonz\u00e1lez-Blas","year":"2023","unstructured":"Bravo Gonz\u00e1lez-Blas, C. et al. SCENIC+: single-cell multiomic inference of enhancers and gene regulatory networks. Nat. Methods 20, 1355\u20131367 (2023).","journal-title":"Nat. Methods"},{"key":"67856_CR38","doi-asserted-by":"publisher","first-page":"11139","DOI":"10.1073\/pnas.1411446111","volume":"111","author":"H Hieronymus","year":"2014","unstructured":"Hieronymus, H. et al. Copy number alteration burden predicts prostate cancer relapse. Proc. Natl. Acad. Sci. USA. 111, 11139\u201311144 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"67856_CR39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41587-022-01468-y","volume":"41","author":"T Gao","year":"2022","unstructured":"Gao, T. et al. Haplotype-aware analysis of somatic copy number variations from single-cell transcriptomes. Nat. Biotechnol. 41, 417\u2013426 (2022).","journal-title":"Nat. Biotechnol."},{"key":"67856_CR40","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nature20788","volume":"541","author":"M Fraser","year":"2017","unstructured":"Fraser, M. et al. Genomic hallmarks of localized, non-indolent prostate cancer. Nature 541, 359\u2013364 (2017).","journal-title":"Nature"},{"key":"67856_CR41","unstructured":"The Cancer Genome Atlas Research Network. The molecular taxonomy of primary prostate cancer. Cell 163, 1011\u20131025 (2015)."},{"key":"67856_CR42","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s40520-023-02466-z","volume":"35","author":"AB Porcaro","year":"2023","unstructured":"Porcaro, A. B. et al. Advanced age is an independent prognostic factor of disease progression in high-risk prostate cancer: results in 180 patients treated with robot-assisted radical prostatectomy and extended pelvic lymph node dissection in a tertiary referral center. Aging Clin. Exp. Res. 35, 1881\u20131889 (2023).","journal-title":"Aging Clin. Exp. Res."},{"key":"67856_CR43","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/s41592-023-01943-7","volume":"20","author":"SJ Fleming","year":"2023","unstructured":"Fleming, S. J. et al. Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender. Nat. Methods 20, 1323\u20131335 (2023).","journal-title":"Nat. Methods"},{"key":"67856_CR44","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1182\/blood-2016-12-689109","volume":"129","author":"M de Bruijn","year":"2017","unstructured":"de Bruijn, M. & Dzierzak, E. Runx transcription factors in the development and function of the definitive hematopoietic system. Blood 129, 2061\u20132069 (2017).","journal-title":"Blood"},{"key":"67856_CR45","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev.immunol.26.021607.090400","volume":"26","author":"T Tamura","year":"2008","unstructured":"Tamura, T., Yanai, H., Savitsky, D. & Taniguchi, T. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26, 535\u2013584 (2008).","journal-title":"Annu. Rev. Immunol."},{"key":"67856_CR46","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.cell.2022.04.019","volume":"185","author":"NE Reticker-Flynn","year":"2022","unstructured":"Reticker-Flynn, N. E. et al. Lymph node colonization induces tumor-immune tolerance to promote distant metastasis. Cell 185, 1924\u20131942 (2022).","journal-title":"Cell"},{"key":"67856_CR47","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.ccell.2023.10.006","volume":"41","author":"JE Hawley","year":"2023","unstructured":"Hawley, J. E. et al. Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer. Cancer Cell 41, 1972\u20131988 (2023).","journal-title":"Cancer Cell"},{"key":"67856_CR48","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1158\/2159-8290.CD-23-1445","volume":"14","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. Single-cell chromatin accessibility analysis reveals the epigenetic basis and signature transcription factors for the molecular subtypes of colorectal cancers. Cancer Discov. 14, 1082\u20131105 (2024).","journal-title":"Cancer Discov."},{"key":"67856_CR49","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1016\/j.molcel.2021.10.013","volume":"81","author":"MJ Regner","year":"2021","unstructured":"Regner, M. J. et al. A multi-omic single-cell landscape of human gynecologic malignancies. Mol. Cell 81, 4924\u20134941 (2021).","journal-title":"Mol. Cell"},{"key":"67856_CR50","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41586-023-06682-5","volume":"623","author":"NV Terekhanova","year":"2023","unstructured":"Terekhanova, N. V. et al. Epigenetic regulation during cancer transitions across 11 tumour types. Nature 623, 432\u2013441 (2023).","journal-title":"Nature"},{"key":"67856_CR51","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano, L., Jord\u0101o, M. J. C. & Joyce, J. A. Therapeutic targeting of the tumor microenvironment. Cancer Discov. 11, 933\u2013959 (2021).","journal-title":"Cancer Discov."},{"key":"67856_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40271-4","volume":"14","author":"R Arora","year":"2023","unstructured":"Arora, R. et al. Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response. Nat. Commun. 14, 5029 (2023).","journal-title":"Nat. Commun."},{"key":"67856_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54145-w","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications. Nat. Commun. 15, 10232 (2024).","journal-title":"Nat. Commun."},{"key":"67856_CR54","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/s41588-025-02193-3","volume":"57","author":"MF Oliveira","year":"2025","unstructured":"Oliveira, M. F. et al. High-definition spatial transcriptomic profiling of immune cell populations in colorectal cancer. Nat. Genet. 57, 1512\u20131523 (2025).","journal-title":"Nat. Genet."},{"key":"67856_CR55","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41588-020-0633-2","volume":"52","author":"JG Reiter","year":"2020","unstructured":"Reiter, J. G. et al. Lymph node metastases develop through a wider evolutionary bottleneck than distant metastases. Nat. Genet. 52, 692\u2013700 (2020).","journal-title":"Nat. Genet."},{"key":"67856_CR56","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.cell.2020.11.018","volume":"184","author":"SK Rehman","year":"2021","unstructured":"Rehman, S. K. et al. Colorectal cancer cells enter a diapause-like DTP state to survive chemotherapy. Cell 184, 226\u2013242 (2021).","journal-title":"Cell"},{"key":"67856_CR57","doi-asserted-by":"crossref","unstructured":"Berthelet, J. et al. The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile. Sci. Adv. 7, eabf4408 (2021).","DOI":"10.1126\/sciadv.abf4408"},{"key":"67856_CR58","doi-asserted-by":"publisher","unstructured":"Serio, R. N. et al. Clonal lineage tracing with somatic delivery of recordable barcodes reveals migration histories of metastatic prostate cancer. Cancer Discov. https:\/\/doi.org\/10.1158\/2159-8290.CD-23-1332 (2024).","DOI":"10.1158\/2159-8290.CD-23-1332"},{"key":"67856_CR59","unstructured":"Guilhamon, P. et al. Single-cell chromatin accessibility profiling of glioblastoma identifies an Invasive cancer stem cell population associated with lower survival. Elife 10, e64090 (2021)."},{"key":"67856_CR60","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s43018-020-00154-9","volume":"2","author":"LM Richards","year":"2021","unstructured":"Richards, L. M. et al. Gradient of developmental and injury response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity. Nat. Cancer 2, 157\u2013173 (2021).","journal-title":"Nat. Cancer"},{"key":"67856_CR61","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41586-024-08356-2","volume":"638","author":"AA Hamed","year":"2025","unstructured":"Hamed, A. A. et al. Gliomagenesis mimics an injury response orchestrated by neural crest-like cells. Nature 638, 499\u2013509 (2025).","journal-title":"Nature"},{"key":"67856_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32701-6","volume":"13","author":"TC Westbrook","year":"2022","unstructured":"Westbrook, T. C. et al. Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity. Nat. Commun. 13, 5345 (2022).","journal-title":"Nat. Commun."},{"key":"67856_CR63","doi-asserted-by":"crossref","unstructured":"Chan, J. M. et al. Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling. Science 377,1180\u20131191 (2022).","DOI":"10.1126\/science.abn0478"},{"key":"67856_CR64","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s43018-022-00431-9","volume":"3","author":"S Deng","year":"2022","unstructured":"Deng, S. et al. Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance. Nat. Cancer 3, 1071\u20131087 (2022).","journal-title":"Nat. Cancer"},{"key":"67856_CR65","doi-asserted-by":"crossref","unstructured":"Morel, K. L. et al. Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice. J Clin Invest. 135, e175680 (2024).","DOI":"10.1172\/JCI175680"},{"key":"67856_CR66","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.devcel.2023.04.010","volume":"58","author":"LF Tshering","year":"2023","unstructured":"Tshering, L. F. et al. Immune mechanisms shape the clonal landscape during early progression of prostate cancer. Dev. Cell 58, 1071\u20131086 (2023).","journal-title":"Dev. Cell"},{"key":"67856_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2014.38","volume":"3","author":"E Kurzejamska","year":"2014","unstructured":"Kurzejamska, E. et al. C\/EBP\u03b2 expression is an independent predictor of overall survival in breast cancer patients by MHCII\/CD4-dependent mechanism of metastasis formation. Oncogenesis 3, e125 (2014).","journal-title":"Oncogenesis"},{"key":"67856_CR68","doi-asserted-by":"publisher","first-page":"103133","DOI":"10.1016\/j.isci.2021.103133","volume":"24","author":"R Gao","year":"2021","unstructured":"Gao, R. et al. Cancer cell immune mimicry delineates onco-immunologic modulation. iScience 24, 103133 (2021).","journal-title":"iScience"},{"key":"67856_CR69","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3389\/fonc.2019.00884","volume":"9","author":"AN Boettcher","year":"2019","unstructured":"Boettcher, A. N. et al. Past, current, and future of immunotherapies for prostate cancer.Front. Oncol. 9, 884 (2019).","journal-title":"Front. Oncol."},{"key":"67856_CR70","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1158\/0008-5472.CAN-19-2948","volume":"80","author":"H-R Cha","year":"2020","unstructured":"Cha, H.-R., Lee, J. H. & Ponnazhagan, S. Revisiting immunotherapy: a focus on prostate cancer. Cancer Res 80, 1615\u20131623 (2020).","journal-title":"Cancer Res"},{"key":"67856_CR71","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.tcb.2023.10.002","volume":"34","author":"FJH Whiting","year":"2024","unstructured":"Whiting, F. J. H., Househam, J., Baker, A.-M., Sottoriva, A. & Graham, T. A. Phenotypic noise and plasticity in cancer evolution. Trends Cell. Biol. 34, 451\u2013464 (2024).","journal-title":"Trends Cell. Biol."},{"key":"67856_CR72","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/S0022-5347(01)64286-1","volume":"158","author":"A Erbersdobler","year":"1997","unstructured":"Erbersdobler, A., Hammerer, P., Huland, H. & Henke, R. P. Numerical chromosomal aberrations in transition-zone carcinomas of the prostate. J. Urol. 158, 1594\u20131598 (1997).","journal-title":"J. Urol."},{"key":"67856_CR73","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nmeth.4396","volume":"14","author":"MR Corces","year":"2017","unstructured":"Corces, M. R. et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat. Methods 14, 959\u2013962 (2017).","journal-title":"Nat. Methods"},{"key":"67856_CR74","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329\u2013337.e4 (2019).","journal-title":"Cell Syst."},{"key":"67856_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02469-x","volume":"22","author":"A Thibodeau","year":"2021","unstructured":"Thibodeau, A. et al. AMULET: a novel read count-based method for effective multiplet detection from single nucleus ATAC-seq data. Genome Biol. 22, 252 (2021).","journal-title":"Genome Biol."},{"key":"67856_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02577-8","volume":"23","author":"D Bredikhin","year":"2022","unstructured":"Bredikhin, D., Kats, I. & Stegle, O. MUON: multimodal omics analysis framework. Genome Biol. 23, 42 (2022).","journal-title":"Genome Biol."},{"key":"67856_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02820-w","volume":"23","author":"A Subramanian","year":"2022","unstructured":"Subramanian, A., Alperovich, M., Yang, Y. & Li, B. Biology-inspired data-driven quality control for scientific discovery in single-cell transcriptomics. Genome Biol. 23, 267 (2022).","journal-title":"Genome Biol."},{"key":"67856_CR78","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s12276-020-0422-0","volume":"52","author":"J Fan","year":"2020","unstructured":"Fan, J., Slowikowski, K. & Zhang, F. Single-cell transcriptomics in cancer: computational challenges and opportunities. Exp. Mol. Med. 52, 1452\u20131465 (2020).","journal-title":"Exp. Mol. Med."},{"key":"67856_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"67856_CR80","doi-asserted-by":"publisher","first-page":"eaav1898","DOI":"10.1126\/science.aav1898","volume":"362","author":"MR Corces","year":"2018","unstructured":"Corces, M. R. et al. The chromatin accessibility landscape of primary human cancers. Science 362, eaav1898 (2018).","journal-title":"Science"},{"key":"67856_CR81","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163\u2013172 (2019).","journal-title":"Nat. Immunol."},{"key":"67856_CR82","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1016\/j.celrep.2018.11.086","volume":"25","author":"GH Henry","year":"2018","unstructured":"Henry, G. H. et al. A cellular anatomy of the normal adult human prostate and prostatic urethra. Cell Rep. 25, 3530\u20133542 (2018).","journal-title":"Cell Rep."},{"key":"67856_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27322-4","volume":"13","author":"H Song","year":"2022","unstructured":"Song, H. et al. Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states. Nat. Commun. 13, 141 (2022).","journal-title":"Nat. Commun."},{"key":"67856_CR84","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s42003-020-01476-1","volume":"3","author":"B Dong","year":"2020","unstructured":"Dong, B. et al. Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer. Commun. Biol. 3, 778 (2020).","journal-title":"Commun. Biol."},{"key":"67856_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"67856_CR86","doi-asserted-by":"crossref","unstructured":"Li, R. et al. Numbat-multiome: inferring copy number variations by combining RNA and chromatin accessibility information from single-cell data. Brief. Bioinform. 26, bbaf516 (2025).","DOI":"10.1093\/bib\/bbaf516"},{"key":"67856_CR87","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589 (2010).","journal-title":"Mol. Cell"},{"key":"67856_CR88","doi-asserted-by":"publisher","unstructured":"Keshavarzian, T. Dynamics of tumor heterogeneity from primary to metastatic dissemination in prostate cancer. Code Ocean https:\/\/doi.org\/10.24433\/CO.2339341.V1 (2024).","DOI":"10.24433\/CO.2339341.V1"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67856-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67856-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67856-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T10:01:43Z","timestamp":1766484103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67856-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["67856"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67856-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G. Grillo reports that at the time of publication, he was an employee of T-One Therapeutics s.r.l. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11339"}}